Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0078
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Histological and Immunohistochemical Features of the Ovarian Malignant Epithelial Tumors and Granulosa Cell Tumors

Pathologia
2019English

RAD001 Offers a Therapeutic Intervention Through Inhibition of mTOR as a Potential Strategy for Esophageal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2010English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2018English

Inhibition of C-Met Is a Potential Therapeutic Strategy for Treatment of Diffuse Large B-Cell Lymphoma

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

NPM1 as a Potential Therapeutic Target for Atypical Teratoid/Rhabd Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy

2014English

Targeted Inhibition of mRNA Translation Initiation Factors as a Novel Therapeutic Strategy for Mature B-Cell Neoplasms

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy